Connected Drug Delivery Devices Market Size to Reach US$ 2,951.5 Million by 2027 | CAGR of 35.6%

According to IMARC Group’s latest report, titled “Connected Drug Delivery Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global connected drug delivery devices market reached a value of US$ 490.9 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 2,951.5 Million by 2027, exhibiting a CAGR of 35.6% during 2022-2027.

Connected drug delivery devices represent smart wireless electronic systems used to support patient supervision and counseling in home settings. They are equipped with dose reminders, adherence trackers, sensors, and monitoring tools to provide instant feedback and education tools. Connected drug delivery devices are convenient and save costs associated with clinic-based treatment. Consequently, they are extensively utilized in the remote monitoring of patients with diabetes, asthma, hepatitis C, hypertension, tuberculosis, multiple sclerosis, clinically isolated syndrome, chronic obstructive pulmonary disease (COPD), liver and renal transplant recipients, etc.

Request for a Free PDF sample report: https://www.imarcgroup.com/connected-drug-delivery-devices-market/requestsample

Note: We are updating our reports, if you want the report with the latest primary and secondary data (2023-2028) including industry trends, market size and Competitive landscape, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.

Connected Drug Delivery Devices Market Trends:

The increasing cost of medical management and the inflating need for improving patient treatment outcomes are primarily augmenting the connected drug delivery devices market. Furthermore, the growing consumer inclination towards home-based care and the escalating demand for preventive measures are positively influencing the global market. Apart from this, the rising number of individuals suffering from chronic diseases is acting as another significant growth-inducing factor. 

Moreover, the widespread adoption of connected drug delivery devices in laboratories and hospitals for maintaining electronic health records (EHR) is also bolstering the market growth. Besides this, the introduction of equipment by leading manufacturers that can be connected to apps and programs, allow data transfer, enable automated tracking, maximize patient safety, etc., is further catalyzing the global market.

Buy This Report Now: https://www.imarcgroup.com/checkout?id=3738&method=1

Note: In this report you will get detailed analysis of the market, growth analysis graphs, historical period analysis, forecast period analysis, major market segmentation, top leading key players of the market, table of content, list of figures, and list of tables.

Competitive Landscape with Key Players:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

• Adherium Ltd.
• BioCorp Production
• Cohero Health Inc. (AptarGroup Inc.)
• Elcam Medical ACS. Ltd
• Findair Sp. z o. o.
• Merck KGaA
• Phillips Medisize (Molex LLC)
• Propeller Health (Resmed Inc.)
• Teva Pharmaceutical Industries Ltd.
• West Pharmaceutical Services Inc.

Key Market Segmentation:

The report has categorized the market based on product, end user and technology.

Breakup by Product:

• Connected Sensors
• Connected Inhaler Sensors
• Connectable Injection Sensors
• Integrated Connected Devices
• Connected Inhalation Devices
• Connected Injection Devices

Breakup by End User:

• Hospitals and Healthcare Providers
• Homecare

Breakup by Technology:

• Bluetooth
• NFC
• Others

Breakup by Region:

• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, South Africa, Others)

Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=3738&flag=C

Key highlights of the report:                                                    

• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Market Trends
• Market Drivers and Success Factors
• Impact of COVID-19
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group

30 N Gould St Ste R

Sheridan, WY 82801 USA

Email: Sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800